Pulmonary Large-cell Neuroendocrine Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2024-05-16
Clinical Trial Update: Durvalumab With Carboplatin and Etoposide Chemotherapy in Pulmonary Large-cell Neuroendocrine Carcinoma (LCNEC) [Phase 2]
A Phase 2 trial is enrolling to evaluate Durvalumab in combination with carboplatin and etoposide for pulmonary large-cell neuroendocrine ca…